β2アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global β2 Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C6509
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、136ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、β2アドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、アルブテロール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール等、用途別セグメントは、等に区分しました。β2アドレナリン受容体作動薬の世界市場概観、企業動向、企業別β2アドレナリン受容体作動薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・β2アドレナリン受容体作動薬の市場概観
・β2アドレナリン受容体作動薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・β2アドレナリン受容体作動薬の企業別販売動向、市場シェア、市場集中度、競争動向
・β2アドレナリン受容体作動薬の世界市場規模
・β2アドレナリン受容体作動薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・β2アドレナリン受容体作動薬のアメリカ市場規模推移
・β2アドレナリン受容体作動薬のカナダ市場規模推移
・β2アドレナリン受容体作動薬のメキシコ市場規模推移
・β2アドレナリン受容体作動薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・β2アドレナリン受容体作動薬のドイツ市場規模推移
・β2アドレナリン受容体作動薬のイギリス市場規模推移
・β2アドレナリン受容体作動薬のロシア市場規模推移
・β2アドレナリン受容体作動薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・β2アドレナリン受容体作動薬の日本市場規模推移
・β2アドレナリン受容体作動薬の中国市場規模推移
・β2アドレナリン受容体作動薬の韓国市場規模推移
・β2アドレナリン受容体作動薬のインド市場規模推移
・β2アドレナリン受容体作動薬の東南アジア市場規模推移
・β2アドレナリン受容体作動薬の南米市場分析（ブラジル、アルゼンチン等）
・β2アドレナリン受容体作動薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・β2アドレナリン受容体作動薬の種類別分析/販売量、売上、市場シェア（アルブテロール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール）
・β2アドレナリン受容体作動薬の用途別分析/市場規模（）
・β2アドレナリン受容体作動薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・β2アドレナリン受容体作動薬の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global β2 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of β2 Adrenoceptor Agonists.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the β2 Adrenoceptor Agonists market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the β2 Adrenoceptor Agonists market by product type and applications/end industries.

Market Segment by Companies, this report covers
Ivax Pharmaceuticals
Physicians Total Care
Baxter Healthcare
Sanofi
Pfizer
Bedford Laboratories
Novartis
Sterimax
Teligent
AstraZeneca
Hikma Pharmaceuticals
Av Kare
Impax Laboratories
PD-Rx Pharmaceuticals
Athenex Pharmaceutical Division
Teva
Marlex Pharmaceuticals
Lannett Company
West-Ward Pharmaceuticals
United Biomedical
Merck
Mylan

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Albuterol
Terbutaline
Salmeterol
Formoterol
Pirbuterol

Market Segment by Applications, can be divided into
Bronchial Asthma
Asthmatic Bronchitis
Emphysema
Others

レポート目次

Table of Contents

1 β2 Adrenoceptor Agonists Market Overview
1.1 Product Overview and Scope of β2 Adrenoceptor Agonists
1.2 Classification of β2 Adrenoceptor Agonists by Types
1.2.1 Global β2 Adrenoceptor Agonists Revenue Comparison by Types (2019-2024)
1.2.2 Global β2 Adrenoceptor Agonists Revenue Market Share by Types in 2018
1.2.3 Albuterol
1.2.4 Terbutaline
1.2.5 Salmeterol
1.2.6 Formoterol
1.2.7 Pirbuterol
1.3 Global β2 Adrenoceptor Agonists Market by Application
1.3.1 Global β2 Adrenoceptor Agonists Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Bronchial Asthma
1.3.3 Asthmatic Bronchitis
1.3.4 Emphysema
1.3.5 Others
1.4 Global β2 Adrenoceptor Agonists Market by Regions
1.4.1 Global β2 Adrenoceptor Agonists Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) β2 Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) β2 Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) β2 Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) β2 Adrenoceptor Agonists Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) β2 Adrenoceptor Agonists Status and Prospect (2014-2024)
1.5 Global Market Size of β2 Adrenoceptor Agonists (2014-2024)
2 Manufacturers Profiles
2.1 Ivax Pharmaceuticals
2.1.1 Business Overview
2.1.2 β2 Adrenoceptor Agonists Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ivax Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.2 Physicians Total Care
2.2.1 Business Overview
2.2.2 β2 Adrenoceptor Agonists Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Physicians Total Care β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.3 Baxter Healthcare
2.3.1 Business Overview
2.3.2 β2 Adrenoceptor Agonists Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Baxter Healthcare β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 β2 Adrenoceptor Agonists Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 β2 Adrenoceptor Agonists Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bedford Laboratories
2.6.1 Business Overview
2.6.2 β2 Adrenoceptor Agonists Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bedford Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis
2.7.1 Business Overview
2.7.2 β2 Adrenoceptor Agonists Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sterimax
2.8.1 Business Overview
2.8.2 β2 Adrenoceptor Agonists Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sterimax β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.9 Teligent
2.9.1 Business Overview
2.9.2 β2 Adrenoceptor Agonists Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Teligent β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 β2 Adrenoceptor Agonists Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hikma Pharmaceuticals
2.11.1 Business Overview
2.11.2 β2 Adrenoceptor Agonists Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hikma Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.12 Av Kare
2.12.1 Business Overview
2.12.2 β2 Adrenoceptor Agonists Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Av Kare β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.13 Impax Laboratories
2.13.1 Business Overview
2.13.2 β2 Adrenoceptor Agonists Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Impax Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.14 PD-Rx Pharmaceuticals
2.14.1 Business Overview
2.14.2 β2 Adrenoceptor Agonists Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.15 Athenex Pharmaceutical Division
2.15.1 Business Overview
2.15.2 β2 Adrenoceptor Agonists Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.16 Teva
2.16.1 Business Overview
2.16.2 β2 Adrenoceptor Agonists Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Teva β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.17 Marlex Pharmaceuticals
2.17.1 Business Overview
2.17.2 β2 Adrenoceptor Agonists Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Marlex Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.18 Lannett Company
2.18.1 Business Overview
2.18.2 β2 Adrenoceptor Agonists Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Lannett Company β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.19 West-Ward Pharmaceuticals
2.19.1 Business Overview
2.19.2 β2 Adrenoceptor Agonists Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.20 United Biomedical
2.20.1 Business Overview
2.20.2 β2 Adrenoceptor Agonists Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 United Biomedical β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.21 Merck
2.21.1 Business Overview
2.2.2 β2 Adrenoceptor Agonists Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Merck β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
2.22 Mylan
2.22.1 Business Overview
2.22.2 β2 Adrenoceptor Agonists Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Mylan β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
3 Global β2 Adrenoceptor Agonists Market Competition, by Players
3.1 Global β2 Adrenoceptor Agonists Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 β2 Adrenoceptor Agonists Players Market Share
3.2.2 Top 10 β2 Adrenoceptor Agonists Players Market Share
3.3 Market Competition Trend
4 Global β2 Adrenoceptor Agonists Market Size by Regions
4.1 Global β2 Adrenoceptor Agonists Revenue and Market Share by Regions
4.2 North America β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.3 Europe β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.5 South America β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
5 North America β2 Adrenoceptor Agonists Revenue by Countries
5.1 North America β2 Adrenoceptor Agonists Revenue by Countries (2014-2019)
5.2 USA β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
5.3 Canada β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
5.4 Mexico β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6 Europe β2 Adrenoceptor Agonists Revenue by Countries
6.1 Europe β2 Adrenoceptor Agonists Revenue by Countries (2014-2019)
6.2 Germany β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.3 UK β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.4 France β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.5 Russia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
6.6 Italy β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Countries
7.1 Asia-Pacific β2 Adrenoceptor Agonists Revenue by Countries (2014-2019)
7.2 China β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.3 Japan β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.4 Korea β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.5 India β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
8 South America β2 Adrenoceptor Agonists Revenue by Countries
8.1 South America β2 Adrenoceptor Agonists Revenue by Countries (2014-2019)
8.2 Brazil β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
8.3 Argentina β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
8.4 Colombia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue β2 Adrenoceptor Agonists by Countries
9.1 Middle East and Africa β2 Adrenoceptor Agonists Revenue by Countries (2014-2019)
9.2 Saudi Arabia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.3 UAE β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.4 Egypt β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.5 Nigeria β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
9.6 South Africa β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
10 Global β2 Adrenoceptor Agonists Market Segment by Type
10.1 Global β2 Adrenoceptor Agonists Revenue and Market Share by Type (2014-2019)
10.2 Global β2 Adrenoceptor Agonists Market Forecast by Type (2019-2024)
10.3 Albuterol Revenue Growth Rate (2014-2024)
10.4 Terbutaline Revenue Growth Rate (2014-2024)
10.5 Salmeterol Revenue Growth Rate (2014-2024)
10.6 Formoterol Revenue Growth Rate (2014-2024)
10.7 Pirbuterol Revenue Growth Rate (2014-2024)
11 Global β2 Adrenoceptor Agonists Market Segment by Application
11.1 Global β2 Adrenoceptor Agonists Revenue Market Share by Application (2014-2019)
11.2 β2 Adrenoceptor Agonists Market Forecast by Application (2019-2024)
11.3 Bronchial Asthma Revenue Growth (2014-2019)
11.4 Asthmatic Bronchitis Revenue Growth (2014-2019)
11.5 Emphysema Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global β2 Adrenoceptor Agonists Market Size Forecast (2019-2024)
12.1 Global β2 Adrenoceptor Agonists Market Size Forecast (2019-2024)
12.2 Global β2 Adrenoceptor Agonists Market Forecast by Regions (2019-2024)
12.3 North America β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.4 Europe β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.6 South America β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure β2 Adrenoceptor Agonists Picture
Table Product Specifications of β2 Adrenoceptor Agonists
Table Global β2 Adrenoceptor Agonists and Revenue (Million USD) Market Split by Product Type
Figure Global β2 Adrenoceptor Agonists Revenue Market Share by Types in 2018
Figure Albuterol Picture
Figure Terbutaline Picture
Figure Salmeterol Picture
Figure Formoterol Picture
Figure Pirbuterol Picture
Table Global β2 Adrenoceptor Agonists Revenue (Million USD) by Application (2014-2024)
Figure β2 Adrenoceptor Agonists Revenue Market Share by Applications in 2018
Figure Bronchial Asthma Picture
Figure Asthmatic Bronchitis Picture
Figure Emphysema Picture
Figure Others Picture
Table Global Market β2 Adrenoceptor Agonists Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (2014-2024)
Table Ivax Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ivax Pharmaceuticals β2 Adrenoceptor Agonists Type and Applications
Table Ivax Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Physicians Total Care Basic Information, Manufacturing Base and Competitors
Table Physicians Total Care β2 Adrenoceptor Agonists Type and Applications
Table Physicians Total Care β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table Baxter Healthcare β2 Adrenoceptor Agonists Type and Applications
Table Baxter Healthcare β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi β2 Adrenoceptor Agonists Type and Applications
Table Sanofi β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer β2 Adrenoceptor Agonists Type and Applications
Table Pfizer β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Bedford Laboratories Basic Information, Manufacturing Base and Competitors
Table Bedford Laboratories β2 Adrenoceptor Agonists Type and Applications
Table Bedford Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis β2 Adrenoceptor Agonists Type and Applications
Table Novartis β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Sterimax Basic Information, Manufacturing Base and Competitors
Table Sterimax β2 Adrenoceptor Agonists Type and Applications
Table Sterimax β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Teligent Basic Information, Manufacturing Base and Competitors
Table Teligent β2 Adrenoceptor Agonists Type and Applications
Table Teligent β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca β2 Adrenoceptor Agonists Type and Applications
Table AstraZeneca β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals β2 Adrenoceptor Agonists Type and Applications
Table Hikma Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Av Kare Basic Information, Manufacturing Base and Competitors
Table Av Kare β2 Adrenoceptor Agonists Type and Applications
Table Av Kare β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table Impax Laboratories β2 Adrenoceptor Agonists Type and Applications
Table Impax Laboratories β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table PD-Rx Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Type and Applications
Table PD-Rx Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Athenex Pharmaceutical Division Basic Information, Manufacturing Base and Competitors
Table Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Type and Applications
Table Athenex Pharmaceutical Division β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva β2 Adrenoceptor Agonists Type and Applications
Table Teva β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Marlex Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Marlex Pharmaceuticals β2 Adrenoceptor Agonists Type and Applications
Table Marlex Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Lannett Company Basic Information, Manufacturing Base and Competitors
Table Lannett Company β2 Adrenoceptor Agonists Type and Applications
Table Lannett Company β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table West-Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Type and Applications
Table West-Ward Pharmaceuticals β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table United Biomedical Basic Information, Manufacturing Base and Competitors
Table United Biomedical β2 Adrenoceptor Agonists Type and Applications
Table United Biomedical β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck β2 Adrenoceptor Agonists Type and Applications
Table Merck β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan β2 Adrenoceptor Agonists Type and Applications
Table Mylan β2 Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2017-2018)
Table Global β2 Adrenoceptor Agonists Revenue (Million USD) by Players (2014-2019)
Table Global β2 Adrenoceptor Agonists Revenue Share by Players (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue Share by Players in 2017
Figure Global β2 Adrenoceptor Agonists Revenue Share by Players in 2018
Figure Global Top 5 Players β2 Adrenoceptor Agonists Revenue Market Share in 2018
Figure Global Top 10 Players β2 Adrenoceptor Agonists Revenue Market Share in 2018
Figure Global β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global β2 Adrenoceptor Agonists Revenue (Million USD) by Regions (2014-2019)
Table Global β2 Adrenoceptor Agonists Revenue Market Share by Regions (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue Market Share by Regions (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue Market Share by Regions in 2018
Figure North America β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Europe β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure South America β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table North America β2 Adrenoceptor Agonists Revenue by Countries (2014-2019)
Table North America β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure North America β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure North America β2 Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure USA β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Canada β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Mexico β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Europe β2 Adrenoceptor Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Europe β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Europe β2 Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure Germany β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure UK β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure France β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Russia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Italy β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Asia-Pacific β2 Adrenoceptor Agonists Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific β2 Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure China β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Japan β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Korea β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure India β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Southeast Asia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table South America β2 Adrenoceptor Agonists Revenue by Countries (2014-2019)
Table South America β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure South America β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure South America β2 Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure Brazil β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Argentina β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Colombia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Middle East and Africa β2 Adrenoceptor Agonists Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa β2 Adrenoceptor Agonists Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa β2 Adrenoceptor Agonists Revenue Market Share by Countries in 2018
Figure Saudi Arabia β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure UAE β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Egypt β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure Nigeria β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Figure South Africa β2 Adrenoceptor Agonists Revenue and Growth Rate (2014-2019)
Table Global β2 Adrenoceptor Agonists Revenue (Million USD) by Type (2014-2019)
Table Global β2 Adrenoceptor Agonists Revenue Share by Type (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue Share by Type (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue Share by Type in 2018
Table Global β2 Adrenoceptor Agonists Revenue Forecast by Type (2019-2024)
Figure Global β2 Adrenoceptor Agonists Market Share Forecast by Type (2019-2024)
Figure Global Albuterol Revenue Growth Rate (2014-2019)
Figure Global Terbutaline Revenue Growth Rate (2014-2019)
Figure Global Salmeterol Revenue Growth Rate (2014-2019)
Figure Global Formoterol Revenue Growth Rate (2014-2019)
Figure Global Pirbuterol Revenue Growth Rate (2014-2019)
Table Global β2 Adrenoceptor Agonists Revenue by Application (2014-2019)
Table Global β2 Adrenoceptor Agonists Revenue Share by Application (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue Share by Application (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue Share by Application in 2018
Table Global β2 Adrenoceptor Agonists Revenue Forecast by Application (2019-2024)
Figure Global β2 Adrenoceptor Agonists Market Share Forecast by Application (2019-2024)
Figure Global Bronchial Asthma Revenue Growth Rate (2014-2019)
Figure Global Asthmatic Bronchitis Revenue Growth Rate (2014-2019)
Figure Global Emphysema Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global β2 Adrenoceptor Agonists Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global β2 Adrenoceptor Agonists Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global β2 Adrenoceptor Agonists Revenue Market Share Forecast by Regions (2019-2024)
Figure North America β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure Europe β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure Asia-Pacific β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure South America β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)
Figure Middle East and Africa β2 Adrenoceptor Agonists Revenue Market Forecast (2019-2024)

Global β1 Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6508 2019年7月 123Pages
本調査レポートは、β1アドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、ドブタミン、デノパミン、ザモテロール、その他等、用途別セグメントは、等に区分しました。β1アドレナリン受容体作動薬の世界市場概観、企業動向、企業別β1アドレナリン受容体作動薬シェア、市場規模推移、...

βアドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global β Adrenoceptor Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6507 2019年7月 139Pages
本調査レポートは、βアドレナリン受容体作動薬の世界市場について調べ、まとめました。種類別セグメントは、イソプレナリン、ドブタミン、サルブタモール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール等、用途別セグメントは、等に区分しました。βアドレナリン受容体作動薬の世界市場概観、企業動向、...

選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Selective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5100 2019年7月 136Pages
本調査レポートは、選択的アゴニストの世界市場について調べ、まとめました。種類別セグメントは、α1選択的アゴニスト、α2選択的アゴニスト、β1選択的アゴニスト、β2選択的アゴニスト等、用途別セグメントは、等に区分しました。選択的アゴニストの世界市場概観、企業動向、企業別選択的アゴニストシェア、市場規模...

非選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Nonselective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4044 2019年7月 138Pages
本調査レポートは、非選択的アゴニストの世界市場について調べ、まとめました。種類別セグメントは、アドレナリン、ノルアドレナリン、イソプレナリン、ドーパミン等、用途別セグメントは、等に区分しました。非選択的アゴニストの世界市場概観、企業動向、企業別非選択的アゴニストシェア、市場規模推移、市場規模予測（2...

オピオイド耐性治療の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Opioid Tolerance Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C4147 2019年8月 120Pages
本調査レポートは、オピオイド耐性治療の世界市場について調べ、まとめました。種類別セグメントは、NMDA拮抗薬、α2 - アドレナリン受容体作動薬等、用途別セグメントは、病院・外来手術センター、リハビリテーションセンター等に区分しました。オピオイド耐性治療の世界市場概観、企業動向、企業別オピオイド耐性...

便秘治療薬の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Constipation Treatment Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C1451 2019年8月 136Pages
本調査レポートは、便秘治療薬の世界市場について調べ、まとめました。種類別セグメントは、下剤、塩化物チャネル活性化剤、5-HT 4受容体作動薬、GC-C作動薬、末梢作用ミューオピオイド受容体拮抗薬等、用途別セグメントは、小売薬局、病院薬局、オンライン薬局等に区分しました。便秘治療薬の世界市場概観、企業...

アドレナリン作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Adrenergic Agonist Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C0064 2019年7月 138Pages
本調査レポートは、アドレナリン作動薬の世界市場について調べ、まとめました。種類別セグメントは、α1アドレナリン作動薬、α2アドレナリン作動薬、β1アドレナリン作動薬、β2アドレナリン作動薬、β3アドレナリン作動薬、α、βアドレナリン作動薬等、用途別セグメントは、等に区分しました。アドレナリン作動薬の...

5Gアプリケーション及びサービスの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global 5G Applications and Services Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6585 2019年7月 136Pages
本調査レポートは、5Gアプリケーション及びサービスの世界市場について調べ、まとめました。種類別セグメントは、エンハンストモバイルブロードバンド、超高信頼性低遅延通信、大規模マシン型通信、固定無線アクセス、その他等、用途別セグメントは、等に区分しました。5Gアプリケーション及びサービスの世界市場概観、...

照明用白色LEDの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global White LEDs for Lighting Applications Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C6381 2019年8月 122Pages
本調査レポートは、照明用白色LEDの世界市場について調べ、まとめました。種類別セグメントは、懐中電灯、シーリングライト、プロジェクションランプ、その他等、用途別セグメントは、公用、家庭用等に区分しました。照明用白色LEDの世界市場概観、企業動向、企業別照明用白色LEDシェア、市場規模推移、市場規模予...

医薬のRFIDの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global RFID in Pharmaceuticals Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4950 2019年7月 136Pages
本調査レポートは、医薬のRFIDの世界市場について調べ、まとめました。種類別セグメントは、RFIDリーダー、RFIDタグ、RFIDミドルウェア等、用途別セグメントは、等に区分しました。医薬のRFIDの世界市場概観、企業動向、企業別医薬のRFIDシェア、市場規模推移、市場規模予測（2019年-2024...

βアドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
β1アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β1 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
非選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Nonselective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, als…
選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Selective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also f…
オピオイド耐性治療の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence,…